Heparin After Mechanical Stroke Embolectomy
Routine post-procedural heparin administration after mechanical thrombectomy for acute ischemic stroke is NOT recommended, as it does not improve functional outcomes and may increase bleeding risk, particularly in patients who received IV thrombolysis.
Evidence-Based Approach
During the Procedure
Heparin is commonly used during mechanical thrombectomy to maintain catheter patency and prevent procedural thrombosis. The typical intraprocedural approach involves:
- Initial bolus of 70 units/kg to maintain ACT around 200-300 seconds 1
- This is standard practice and distinct from post-procedural anticoagulation
Post-Procedural Management: The Critical Decision
Routine post-procedural heparin should be avoided based on the most recent evidence:
- A 2024 meta-analysis found that heparin administration during/after MT was associated with worse functional outcomes (90-day mRS 0-2: OR 0.88, p=0.023) and increased distal embolization (OR 1.25, p=0.04) 2
- Patients who received IV thrombolysis had significantly higher risk of symptomatic ICH when heparin was added (OR 2.94, p=0.009) 2
- A 2019 real-world study showed heparin use was inversely associated with successful reperfusion (OR 0.48, p=0.045) 3
When Post-Procedural Heparin MAY Be Considered
Selective use only in high-risk situations 1:
- Angiographically visible arterial dissection
- Mural thrombosis identified during procedure
- Progressive or new neurological symptoms post-procedure
- Partial recanalization with persistent distal emboli
If used in these scenarios:
VTE Prophylaxis vs. Therapeutic Anticoagulation
This is a critical distinction:
VTE prophylaxis IS recommended for immobile stroke patients:
- Low-molecular-weight heparin (enoxaparin) or unfractionated heparin for patients with renal failure 4
- Can be started immediately if no contraindication (e.g., systemic or intracranial hemorrhage) 4
- This is prophylactic dosing, not therapeutic anticoagulation
Therapeutic anticoagulation for cardioembolic stroke:
- Immediate heparin after ischemic stroke is NOT recommended 5
- The 2016 ESC guidelines explicitly state: "Anticoagulation with heparin or LMWH immediately after an ischemic stroke is not recommended in AF patients" (Class III harm, Level A) 5
Timing of Oral Anticoagulation Initiation
For patients requiring long-term anticoagulation (e.g., atrial fibrillation):
The 1-3-6-12 day rule based on stroke severity 5, 6:
- TIA or small stroke: 1-3 days after event
- Moderate stroke: 6-8 days after event
- Large stroke: 12-14 days after event
- Repeat brain imaging to exclude hemorrhagic transformation before starting 5, 6
Bridging with heparin is NOT recommended due to rapid onset of NOACs and increased bleeding risk 6
Common Pitfalls to Avoid
- Confusing VTE prophylaxis with therapeutic anticoagulation - prophylactic doses are appropriate and recommended for immobile patients
- Reflexively starting heparin "for stroke" - this increases harm without benefit in most cases
- Starting heparin before imaging excludes hemorrhagic transformation - always image first
- Using heparin as a bridge to oral anticoagulation - NOACs have rapid onset; bridging increases bleeding risk without benefit
Practical Algorithm
Post-thrombectomy anticoagulation decision:
Successful recanalization, no complications:
- NO therapeutic heparin
- VTE prophylaxis if immobile
- Plan oral anticoagulation timing based on stroke size (1-3-6-12 rule)
Arterial dissection, mural thrombus, or progressive symptoms:
- Consider therapeutic heparin (aPTT 1.5-2.3x control) for 24 hours
- Close neurological monitoring
- Weigh against hemorrhagic risk
Patient received IV tPA:
- Avoid post-procedural heparin - highest bleeding risk 2
- VTE prophylaxis only
Atrial fibrillation requiring anticoagulation: